Jian James Huang
Known title: EVP, APACCIK: 0001781021
Associated companies
Transaction History
| ADNT | ▲ Buy | Option Exercise | 3,667 | $0 | 11/17/2025 | View on chart |
| ADNT | ▼ Sell | Other | 3,667 | $70K | 11/17/2025 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 6,433 | $0 | 11/16/2025 | View on chart |
| ADNT | ▼ Sell | Other | 6,433 | $129K | 11/16/2025 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 60,512 | $0 | 11/14/2025 | View on chart |
| ADNT | ▼ Sell | Other | 60,512 | $1.2M | 11/14/2025 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 6,955 | $0 | 11/13/2025 | View on chart |
| ADNT | ▼ Sell | Other | 6,955 | $139K | 11/13/2025 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 3,017 | $0 | 11/18/2024 | View on chart |
| ADNT | ▼ Sell | Other | 3,017 | $60K | 11/18/2024 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 3,558 | $0 | 11/17/2024 | View on chart |
| ADNT | ▼ Sell | Other | 3,558 | $71K | 11/17/2024 | View on chart |
| ADNT | ▼ Sell | Other | 6,433 | $128K | 11/16/2024 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 6,433 | $0 | 11/16/2024 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 7,188 | $0 | 11/14/2024 | View on chart |
| ADNT | ▼ Sell | Other | 7,188 | $147K | 11/14/2024 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 4,543 | $0 | 11/19/2023 | View on chart |
| ADNT | ▼ Sell | Other | 4,543 | $149K | 11/19/2023 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 2,928 | $0 | 11/18/2023 | View on chart |
| ADNT | ▼ Sell | Other | 2,928 | $96K | 11/18/2023 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 3,599 | $0 | 11/17/2023 | View on chart |
| ADNT | ▼ Sell | Other | 3,599 | $118K | 11/17/2023 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 40,086 | $0 | 11/16/2023 | View on chart |
| ADNT | ▼ Sell | Other | 40,086 | $1.3M | 11/16/2023 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 4,410 | $0 | 11/19/2022 | View on chart |
| ADNT | ▼ Sell | Other | 4,410 | $174K | 11/19/2022 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 8,032 | $0 | 11/18/2022 | View on chart |
| ADNT | ▼ Sell | Other | 8,032 | $318K | 11/18/2022 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 10,149 | $0 | 11/17/2022 | View on chart |
| ADNT | ▼ Sell | Other | 10,149 | $391K | 11/17/2022 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 4,529 | $0 | 7/1/2022 | View on chart |
| ADNT | ▼ Sell | Other | 4,529 | $136K | 7/1/2022 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 222 | $6K | 2/15/2022 | View on chart |
| ADNT | ▼ Sell | Other | 222 | $11K | 2/15/2022 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 4,409 | $0 | 11/19/2021 | View on chart |
| ADNT | ▼ Sell | Other | 4,409 | $203K | 11/19/2021 | View on chart |
| ADNT | ▼ Sell | Other | 5,059 | $237K | 11/18/2021 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 2,453 | $0 | 11/18/2021 | View on chart |
| ADNT | ▼ Sell | Other | 2,453 | $115K | 11/18/2021 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 5,059 | $0 | 11/18/2021 | View on chart |
| ADNT | ▲ Buy | Option Exercise | 812 | $0 | 10/1/2021 | View on chart |
| ADNT | ▼ Sell | Other | 812 | $34K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets
Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.
Adient Q4 Earnings Set for Nov. 4 as Analysts Trim Targets. Adient will report fourth-quarter and full-year fiscal 2026 results on November 4, 2026. Ahead of this announcement, Barclays and UBS both lowered their price targets to $22 and $23, respectively, while maintaining their ratings. Recent commentary also highlights strong backlog growth driven by onshoring initiatives and new customer wins.